Skip to main content
LFVN
NASDAQ Life Sciences

Director Judd Buys Over $152K in LifeVantage Stock Following Q2 Decline

Analysis by Wiseek AI
Sentiment info
Positive
Importance info
7
Price
$4.64
Mkt Cap
$57.826M
52W Low
$3.9
52W High
$17.64
Market data snapshot near publication time

Summary

Director Dayton Judd purchased over $152,000 worth of LifeVantage Corporation common stock in open market transactions, signaling confidence after the company's recent negative financial reports.


Key Events

  • Director Initiates Significant Stock Purchase

    Director Dayton Judd acquired 33,197 shares of LifeVantage common stock through open market purchases, increasing his direct holdings.

  • Substantial Investment Value

    The total value of these transactions amounted to $152,422.11, executed across three separate purchases.

  • Timing Follows Negative Financial Reports

    These purchases occurred between February 26 and March 2, 2026, following the company's Q2 2026 report on February 4, 2026, which detailed substantial revenue and net income declines and a CEO retirement.


Analysis

This significant open market purchase by Director Dayton Judd comes shortly after LifeVantage reported a substantial decline in Q2 revenue and net income, along with the announcement of a CEO retirement and a share repurchase program. Judd's acquisition of over $152,000 in shares, representing a notable portion of the company's market capitalization, suggests a vote of confidence from a board member amidst recent challenges. Investors may view this as a positive signal, indicating that at least one insider believes the stock is undervalued following the negative news.

At the time of this filing, LFVN was trading at $4.64 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $57.8M. The 52-week trading range was $3.90 to $17.64. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LFVN - Latest Insights

LFVN
May 06, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.90
Real-time Price: $9.15 info
Change: +$4.25 (+87%) info
Market Cap: $114.173M info
LFVN
May 06, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $4.90
Real-time Price: $9.15 info
Change: +$4.25 (+87%) info
Market Cap: $114.173M info
LFVN
May 06, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $5.14
Real-time Price: $9.15 info
Change: +$4.01 (+78%) info
Market Cap: $114.173M info
LFVN
Apr 21, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.25
Real-time Price: $9.15 info
Change: +$3.90 (+74%) info
Market Cap: $114.173M info
LFVN
Apr 16, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.57
Real-time Price: $9.15 info
Change: +$4.58 (+100%) info
Market Cap: $114.173M info
LFVN
Apr 02, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.20
Real-time Price: $9.15 info
Change: +$4.95 (+118%) info
Market Cap: $114.173M info
LFVN
Mar 02, 2026, 6:44 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $4.64
Real-time Price: $9.15 info
Change: +$4.51 (+97%) info
Market Cap: $114.173M info
LFVN
Feb 04, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.78
Real-time Price: $9.15 info
Change: +$5.37 (+142%) info
Market Cap: $114.173M info
LFVN
Feb 04, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.78
Real-time Price: $9.15 info
Change: +$5.37 (+142%) info
Market Cap: $114.173M info